BCL2 and head and neck cancer: Antisense oligodeoxynucleotides (ASODN) and short interfering RNA (siRNA) molecules have been used to silence the expression of anti-apoptotic Bcl-2 protein in head and neck cancer cells, which proved to successfully induce cancer cell death in response to chemotherapy both in vitro and in vivo [9,10].